Sustained virologic response and changes in liver fibrosis parameters following 12-wk administration of generic sofosbuvir and daclatasvir in HIV/HCV-coinfected patients with HCV genotype 4 infection. [electronic resource]
- Transactions of the Royal Society of Tropical Medicine and Hygiene 04 2020
- 232-240 p. digital
Publication Type: Journal Article
1878-3503
10.1093/trstmh/trz120 doi
Antiviral Agents--therapeutic use Carbamates Coinfection--drug therapy Drug Therapy, Combination Genotype HIV Infections--complications Hepacivirus--genetics Hepatitis C, Chronic--complications Humans Imidazoles Liver Cirrhosis--complications Prospective Studies Pyrrolidines Ribavirin--therapeutic use Sofosbuvir--therapeutic use Sustained Virologic Response Treatment Outcome Valine--analogs & derivatives